19 November 2009 - Covance has entered into a biomarker alliance and services agreement with Rules-Based Medicine, a provider of multiplexed-protein-biomarker testing to the pharmaceutical industry.
Covance will use RBM as its exclusive third-party provider of multiplexed-protein-biomarker testing services and RBM will use Covance as its exclusive referral source for laboratory-testing services.
